Document Detail

Increased anticoagulant response to low molecular weight heparin in plasma from patients with advanced cirrhosis.
MedLine Citation:
PMID:  22712870     Owner:  NLM     Status:  Publisher    
Introduction: cirrhotic patients may present thrombotic complications that warrant anticoagulant therapy. However, the efficacy of low molecular weight heparin (LMWH) in this clinical setting is still unclear. Aims/methods: to evaluate the in vitro effect of LMWH on thrombin generation (TG) in cirrhotic patients at different stages of liver disease. Thirty cirrhotics (10 Child-A, 10 Child-B, 10 Child-C), 10 subjects with inherited type 1 antithrombin (AT) defect, and 10 healthy controls were studied. TG was determined at baseline and with anti-Xa levels after the addition of enoxaparin at 0.35U anti-Xa/mL and 0.7U anti-Xa/mL. Endogenous thrombin potential (ETP) ratio at 0.35U anti-Xa/mL and 0.7U anti-Xa/mL were obtained by dividing ETP with LMWH by ETP at baseline. Results: Mean AT levels in all cirrhotic subgroups and in patients with AT deficiency were significantly lower than in controls. The 0.35ETP ratio was significantly lower in cirrhotics than in controls (0.26±0.1 vs 0.48±0.1, p<.001) and the reduction paralleled the severity of liver disease, despite the concomitant decrease in AT and anti-Xa activity. AT-deficient subjects showed a significantly increased 0.35ETP ratio compared to both cirrhotics and controls (0.69±1 vs 0.26±0.1, p<.001, and vs 0.48±0.1, p=.04 respectively). LMWH at 0.7U anti-Xa/mL completely inhibited TG in 9/30 cirrhosis patients with more advanced liver disease (Child B and C), while complete TG abolition was seen in only 1/10 controls. Conclusions: cirrhotic patients show an increased response to LMWH, which correlates with the severity of liver disease, despite reduced AT and anti-Xa activity levels. Thrombin generation may be a useful tool to monitor the response to LMWH in cirrhotic patients. © 2012 International Society on Thrombosis and Haemostasis.
Senzolo Marco; R K Isabel; R Valeria; R Claudia; G Sabrina; C P; Z Patrizia; S M Teresa; S Paolo
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-19
Journal Detail:
Title:  Journal of thrombosis and haemostasis : JTH     Volume:  -     ISSN:  1538-7836     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101170508     Medline TA:  J Thromb Haemost     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 International Society on Thrombosis and Haemostasis.
Multivisceral Transplant Unit, Department of Surgical and Gastroenterological Sciences. Padua University Hospital, Padua, Italy Second Chair of Internal Medicine, Department of Cardiologic, Thoracic, and Vascular Sciences, 2nd Chair of Internal Medicine. Padua University Hospital, Padua, Italy Section of Laboratory Medicine. Padua University Hospital, Padua, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Next Document:  Outcome of children with hyperventilation-induced high-amplitude rhythmic slow activity with altered...